Login
Search
Search
0 Dates
2026
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
CPC 2026
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Timeliness of the First Heart Failure Consultation and Outcomes in HFrEF: Establishing a Temporal Threshold for Follow-Up
Session:
Sessão de Posters 10 - Cuidados modernos na insuficiência cardíaca: congestão, metabolismo e resultados
Speaker:
João Fernandes Pedro
Congress:
CPC 2026
Topic:
D. Heart Failure
Theme:
10. Chronic Heart Failure
Subtheme:
10.6 Chronic Heart Failure - Clinical
Session Type:
Posters Eletrónicos
FP Number:
---
Authors:
João Fernandes Pedro; Diogo Ferreira; Marta Vilela; Ana Francês; Fátima Salazar; Nuno Lousada; Joana Rigueira; Rafael Santos; Doroteia Silva; Fausto J. Pinto; Dulce Brito; João R. Agostinho
Abstract
<p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Introduction</strong></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">Timely follow-up after hospital discharge or initial diagnosis is recommended to reduce adverse outcomes in HFrEF. However, objective evidence defining the maximum acceptable waiting time for the first consultation is lacking, and the prognostic impact of delayed access to specialized follow-up in real-life practice remains unclear.</span></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Aim</strong></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">To evaluate whether waiting time until the first consultation predicts the occurrence of HF events (hospitalization or death) in patients with HFrEF and to explore whether a temporal threshold could be identified beyond which prognosis significantly worsens.</span></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Methods</strong></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">A retrospective cohort study of HFrEF patients followed at a tertiary hospital’s outpatient HF clinic was conducted. Baseline clinical, laboratory, and echocardiographic data were collected. Patients were followed for 3 years for HF events. Mean waiting time for the first consultation was compared between patients with and without events. A ROC analysis identified the optimal waiting-time threshold, which informed subsequent Kaplan–Meier and Cox regression analyses, based on the identified threshold.</span></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Results</strong></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">A total of 200 HFrEF patients were included (mean age 65.1 ± 14.6 years; LVEF 27.5 ± 8.2%). Most were in NYHA class II (46.5%). Ischemic etiology was the most common (47.5%), followed by dilated cardiomyopathy (35.5%). Mean waiting time for the first consultation was 59.9 ± 63 days.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">During the 3-year follow-up period, 26 patients (13%) experienced an HF event. Patients with events had a significantly longer waiting time compared with those without events (97.3 ± 81.1 vs. 54.6 ± 58.2 days; mean difference 42.7 days; 95% CI –68.3 to –17.2; p=0.001). ROC curve analysis demonstrated meaningful discrimination and identified 60 days as the optimal threshold to predict events. Kaplan–Meier curves showed a significantly higher cumulative incidence of HF events among patients seen ≥60 days after referral (log-rank p<0.001). Cox regression confirmed that waiting ≥60 days for a first consultation was strongly associated with an increased risk of HF events (HR 5.73; 95% CI 2.41–13.65; p<0.001).</span></span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000"><strong>Conclusion</strong></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">Delayed access to the first HF consultation is a strong predictor of mortality or hospitalization in patients with HFrEF. A waiting time ≥60 days identifies patients at higher risk, suggesting that earlier follow-up may be clinically meaningful. These findings support the need for structured pathways ensuring timely post-diagnosis or post-discharge evaluation.</span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site